Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.24.1.1.u2
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Accrued Liabilities, Current [Abstract]    
External research and preclinical development $ 8,220 $ 8,001
Employee compensation and benefits 2,487 6,993
Professional fees 1,022 1,015
Facilities and other 152 137
Accrued expenses $ 11,881 $ 16,146